RxDoctor Payments Data

Travis Tierney, MD

Neurological Surgery · South Miami, FLNPI 1467598003

Payments from drug & device makers

What this record shows

5 manufacturers reported payments, led by Abbott at 50.3% of the total. That places this record below the midpoint for neurological surgery clinicians in FL, where the typical reported total is $5,245.

$3,870in general payments, 2019–2025

Across 31 payments — averaging $124.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Insightec,inc$1K
  • Insightec,ltd$452
  • Clearpoint Neuro, Inc.$121
  • SK Life Science, Inc.$48
$295in research payments, 2019–2025

Across 1 payment — averaging $295.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Insightec,ltd$295

What the payments were for

  • Travel & lodging$2,16956%
  • Food & beverage$1,70044%

General payments by program year

19
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott12$1,947
Insightec,inc15$1,301
Insightec,ltd1$452
Clearpoint Neuro, Inc.1$121
SK Life Science, Inc.2$48

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,870 in reported general payments places this provider in the 45th percentile of 556 neurological surgery providers in Florida.

See all neurological surgery providers in Florida

Medicare billing

Part B allowed, 2024
$24,374
Medicare patients
43
Services billed
74

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NeuproRotigotine23$19,133
Carbidopa-LevodopaCarbidopa/Levodopa12$288
Primidone11$174
Dexamethasone15$116

Paid to pharmacies, not to this prescriber.

Other neurological surgery in South Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →